Authors: Platt, FM Jeyakumar, M Andersson, U Priestman, DA Dwek, RA Butters, TD Cox, TM Lachmann, RH Hollak, C Aerts, JMFG Van Weely, S Hrebicek, M Moyses, C Gow, I Elstein, D Zimran, A

Citation: Fm. Platt et al., Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy, J INH MET D, 24(2), 2001, pp. 275-290

Authors: Maaswinkel-Mooij, P Hollak, C van Eysden-Plaisier, M Prins, M Aerts, H Poll, R

Citation: P. Maaswinkel-mooij et al., The natural course of Gaucher disease in The Netherlands: Implications formonitoring of disease manifestations, J INH MET D, 23(1), 2000, pp. 77-82

Authors: Cox, T Lachmann, R Hollak, C Aerts, J van Weely, S Hrebicek, M Platt, F Butters, T Dwek, R Moyses, C Gow, I Elstein, D Zimran, A

Citation: T. Cox et al., Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis, LANCET, 355(9214), 2000, pp. 1481-1485